A detailed history of Farther Finance Advisors, LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 75 shares of LEGN stock, worth $3,201. This represents 0.0% of its overall portfolio holdings.

Number of Shares
75
Previous 57 31.58%
Holding current value
$3,201
Previous $2.62 Million 39.34%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$43.55 - $59.88 $783 - $1,077
18 Added 31.58%
75 $3.66 Million
Q2 2024

Jul 31, 2024

BUY
$39.5 - $57.22 $237 - $343
6 Added 11.76%
57 $2.62 Million
Q1 2024

May 13, 2024

BUY
$55.06 - $69.99 $2,808 - $3,569
51 New
51 $2.92 Million

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $7.15B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.